Retinal cotton wool spot associated with cladribine therapy for multiple sclerosis. Mult Scler Relat Disord 2021 Feb;48:102661
Date
12/16/2020Pubmed ID
33321344DOI
10.1016/j.msard.2020.102661Scopus ID
2-s2.0-85097757289 (requires institutional sign-in at Scopus site) 1 CitationAbstract
Cladribine has been shown to lower relapse rates and decrease disease progression in patients with relapsing forms of multiple sclerosis (MS). Reported adverse effects with use of cladribine include lymphopenia, neutropenia, and infections. Ocular complications have not previously been described with cladribine. We report the case of a patient developing visual symptoms and a large retinal cotton wool spot in association with initiation of cladribine therapy.
Author List
Gummi R, Walsh RD, Ahmad BAuthors
Baseer Ahmad MD Associate Professor in the Ophthalmology and Visual Sciences department at Medical College of WisconsinRyan Walsh MD Associate Professor in the Ophthalmology and Visual Sciences department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
CladribineHumans
Immunosuppressive Agents
Lymphopenia
Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting